Suppr超能文献

[可待因-对乙酰氨基酚联合治疗与曲马多-对乙酰氨基酚治疗对中重度下腰痛控制效果的比较研究]

[Study of codeine-paracetamol combination treatment compared with tramadol-paracetamol in the control of moderate-to-severe low back pain].

作者信息

Colini Baldeschi G, Cobianchi M R

机构信息

UOSD Terapia Antalgica, Azienda Ospedaliera S. Giovanni Addolorata, Roma, Italia.

出版信息

Minerva Med. 2012 Jun;103(3):177-82.

Abstract

AIM

The objective of this study was to compare the analgesic efficacy and tolerability of tramadol hydrochloride compared with codeine phosphate in combination with paracetamol in patients with moderate-to-severe low back pain caused by osteoarthritis. In fact, while paracetamol is the analgesic of choice for this disease, in cases where this treatment may be ineffective, the therapeutic choice involves the addition of weak opioids. Due to the chronic nature of the disease, these drugs represent a safer alternative compared to anti-inflammatory drugs (NSAIDs) and selective inhibitors of cyclooxygenase 2 (COX-2).

METHODS

In the present study two combination treatments were considered: codeine-paracetamol (respectively 30 mg and 500 mg) and tramadol-paracetamol (respectively 37.5 mg and 325 mg). The study duration was 4 weeks and involved 38 patients (mean age 64.7 years). The effectiveness of the two treatments was assessed in terms of analgesic efficacy, tolerability and safety.

RESULTS

The results recorded after a week of treatment and at the end of the study showed a difference in favour of codeine-paracetamol association which showed slightly higher values ​​in pain improvement and, above all, was better tolerated in terms of adverse events and drop out.

CONCLUSION

The study, although conducted on a limited number of patients and for a relatively short time, demonstrates the greater efficacy and tolerability of the association codeine-paracetamol compared to tramadol-paracetamol.

摘要

目的

本研究的目的是比较盐酸曲马多与磷酸可待因联合对乙酰氨基酚在骨关节炎所致中重度腰痛患者中的镇痛效果和耐受性。事实上,虽然对乙酰氨基酚是该疾病的首选镇痛药,但在该治疗可能无效的情况下,治疗选择包括添加弱阿片类药物。由于该疾病的慢性性质,与抗炎药(非甾体抗炎药)和环氧化酶2(COX-2)选择性抑制剂相比,这些药物是更安全的选择。

方法

在本研究中,考虑了两种联合治疗:可待因 - 对乙酰氨基酚(分别为30毫克和500毫克)和曲马多 - 对乙酰氨基酚(分别为37.5毫克和325毫克)。研究持续时间为4周,涉及38名患者(平均年龄64.7岁)。从镇痛效果、耐受性和安全性方面评估了两种治疗的有效性。

结果

治疗一周后和研究结束时记录的结果显示,可待因 - 对乙酰氨基酚联合治疗更具优势,在疼痛改善方面显示出略高的值,最重要的是,在不良事件和退出方面耐受性更好。

结论

该研究虽然在有限数量的患者中进行且时间相对较短,但证明了可待因 - 对乙酰氨基酚联合治疗比曲马多 - 对乙酰氨基酚联合治疗具有更高的疗效和耐受性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验